BET inhibitor ABBV-075 perturbed pathways in prostate cancer organoid MSK-PCa17
To study global transcriptomic changes with BET inhibition in MSK-PCa17 cells and correlate with growth inhibition Overall design: MSK-PCa17 organoids  were treated with increasing doses of ABBV-075 for 4 hours